FSA Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
FSA Wealth Management's PFE Position: Q3 2025 in Review
FSA Wealth Management increased its Pfizer (PFE) stake by 0.08% in Q3 2025, buying an estimated $99 and bringing the position to 5,111 shares worth $130K. The position accounts for 0.05% of the portfolio, ranked #75.
FSA Wealth Management first reported a position in PFE in Q4 2019 and has held it in 14 quarters since. The position peaked at $546K in Q4 2019. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- FSA Wealth Management held 5,111 shares of Pfizer worth $130K as of Q3 2025.
- FSA Wealth Management bought 4 Pfizer shares in Q3 2025, an estimated $99.
- Pfizer made up 0.05% of FSA Wealth Management's portfolio in Q3 2025, its #75 holding.
- FSA Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 14 quarters since.
- FSA Wealth Management's Pfizer position peaked at $546K in Q4 2019.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.